Thank you for choosing to subscribe to Strykerâs investor email alert(s).
In order for us to validate your subscription and consent to opt-in for email alerts, please click on the following activation link:
https://investors.stryker.com/investor-resources/investor-email-alerts/email-alert-activation/default.aspx?token=6A01CC10-08A5-44C9-8116-5FED0AD9A9E1
If the link above is not clickable, please copy and paste it into your browser.
Thank you,
Stryker
In order for us to validate your subscription and consent to opt-in for email alerts, please click on the following activation link:
https://investors.stryker.com/investor-resources/investor-email-alerts/email-alert-activation/default.aspx?token=6A01CC10-08A5-44C9-8116-5FED0AD9A9E1
If the link above is not clickable, please copy and paste it into your browser.
Thank you,
Stryker
Date Sent: 1/8/2024 4:28:05 PM | Powered by Q4 Inc. |
-
This email was sent
January 8, 2024 9:28pm
-
Country:
United States
-
Tags
Medicine B2B Enterprise